NEKTR
Updated 39 days ago
Finisklin Business & Technology Park, Sligo, Ireland
The A3IS platform has been developed as a topical medicine intended for the treatment of several infectious diseases with a clear focus in the area of dermatology-based indications...
infection, also known as onychomycosis. Mycosinate™, a specific formulation that is ideal for the treatment of fungal nail disease, was developed from the A3IS platform...
Due to A3IS's broad- spectrum antimicrobial activity and excellent safety profile on skin, there are several other indications which we are currently pursuing for A3IS that are at an earlier stage of development.
Also known as: Nektr Technologies